Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population
|ClinicalTrials.gov Identifier: NCT02277366|
Recruitment Status : Terminated (We have recruited some patients, but we haven't found any significant result by bronchoscopy in the high risk population.)
First Posted : October 29, 2014
Last Update Posted : November 16, 2015
|Condition or disease||Intervention/treatment|
|Lung Neoplasms||Procedure: Fluorescence Bronchoscopy/Narrow Band Bronchoscopy|
|Study Type :||Observational|
|Actual Enrollment :||400 participants|
|Official Title:||A Multi-center Randomized Control Study of Bronchoscopy in Early Lung Cancer Screening of High Risk Population|
|Study Start Date :||May 2015|
|Estimated Primary Completion Date :||November 2017|
|Estimated Study Completion Date :||November 2017|
Fluorescence/Narrow Band Bronchoscopy
All patients in the group are examined by Fluorescence Bronchoscopy and Narrow Band Bronchoscopy to make a early detection of lung cancer.
Procedure: Fluorescence Bronchoscopy/Narrow Band Bronchoscopy
Fluorescence Bronchoscopy and Narrow Band Bronchoscopy are used in the Fluorescence/Narrow Band Bronchoscopy group to make a diagnosis of lung cancer.
All patients in this group are examined by routine bronchoscopy to make a early detection of lung cancer.
- Diagnostic yield of Lung Cancer [ Time Frame: 1 week ]
- Number of Participants with Serious Adverse Events [ Time Frame: 1 week ]
- Cost of all examinations to make a diagnosis [ Time Frame: 2 weeks ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02277366
|Xi'an, Shaanxi, China, 710038|
|Principal Investigator:||Faguang Jin, Ph.D, MD||Tang-Du Hospital|